APIE Therapeutics Inc.
APIE Therapeutics is a preclinical Biopharma pioneering a pipeline of drugs to repair and regenerate damage to the small vasculature niche, which is associated to the precursor of many chronic and fibrotic diseases pathophysiology. Our drug portfolio consist of over 800 potent and selective Apelin Receptor Agonists.
APIE Therapeutics is developing therapies for fibrosis and related diseases. Its biology platform is the activation of the Apelinergic System signaling pathway via Apelin/APJ receptors agonist drug therapies.
Company Location
P.O. Box 1985
Cary
NC
27511
126 Arabella Court
Cary
NC
27518
Phone
(919) 594-1665
County
Region
Company Details
Company type
Year founded
2020
Employment range in NC
US headquarters
North Carolina
Global headquarters
United States
Primary site activity
All company activities